Chemical Component Summary

Name2-(pyridin-2-yl)-N-(5-{4-[6-({[3-(trifluoromethoxy)phenyl]acetyl}amino)pyridazin-3-yl]butyl}-1,3,4-thiadiazol-2-yl)acetamide
Identifiers~{N}-[6-[4-[5-(2-pyridin-2-ylethanoylamino)-1,3,4-thiadiazol-2-yl]butyl]pyridazin-3-yl]-2-[3-(trifluoromethyloxy)phenyl]ethanamide
FormulaC26 H24 F3 N7 O3 S
Molecular Weight571.574
TypeNON-POLYMER
Isomeric SMILESc1ccnc(c1)CC(=O)Nc2nnc(s2)CCCCc3ccc(nn3)NC(=O)Cc4cccc(c4)OC(F)(F)F
InChIInChI=1S/C26H24F3N7O3S/c27-26(28,29)39-20-9-5-6-17(14-20)15-22(37)31-21-12-11-18(33-34-21)7-1-2-10-24-35-36-25(40-24)32-23(38)16-19-8-3-4-13-30-19/h3-6,8-9,11-14H,1-2,7,10,15-16H2,(H,31,34,37)(H,32,36,38)
InChIKeyPRAAPINBUWJLGA-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count64
Chiral Atom Count0
Bond Count67
Aromatic Bond Count23

Drug Info: DrugBank

DrugBank IDDB15232 
NameTelaglenastat
Groups investigational
DescriptionTelaglenastat is under investigation in clinical trial NCT02071862 (Study of the Glutaminase Inhibitor CB-839 in Solid Tumors).
SynonymsTelaglenastat
Categories
  • Acetamides
  • Amides
  • Benzene Derivatives
  • Sulfur Compounds
  • Thiazoles
CAS number1439399-58-2

Related Resource References

Resource NameReference
Pharos CHEMBL3639788
PubChem 71577426
ChEMBL CHEMBL3639788